111 (NASDAQ:YI) Director Sells $10,120.00 in Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 44,000 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $0.23, for a total transaction of $10,120.00. Following the completion of the transaction, the director owned 495,462 shares in the company, valued at $113,956.26. This trade represents a 8.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Friday, June 12th, Yang Luke Chen sold 49,920 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $11,481.60.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The stock was sold at an average price of $0.25, for a total transaction of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $388.80.

111 Price Performance

Shares of NASDAQ YI opened at $4.41 on Friday. 111, Inc. Sponsored ADR has a twelve month low of $2.48 and a twelve month high of $11.17. The firm has a fifty day simple moving average of $5.76 and a 200 day simple moving average of $5.68. The company has a market capitalization of $38.76 million, a PE ratio of -3.15 and a beta of 0.60.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, 111 presently has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.